share_log

Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Floyd Eric

Virpax制药 | 4:持股变动声明-董事 Floyd Eric

美股SEC公告 ·  01/31 16:30

Moomoo AI 已提取核心信息

In a recent transaction, Eric Floyd, associated with Virpax Pharmaceuticals Inc. [VRPX], executed a stock transaction on January 29, 2024. The specific details regarding the nature of the transaction, such as the action type, number of shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Eric Floyd to the issuer was also not specified. Investors are advised to seek additional information to fully understand the implications of this transaction on their investment decisions.
In a recent transaction, Eric Floyd, associated with Virpax Pharmaceuticals Inc. [VRPX], executed a stock transaction on January 29, 2024. The specific details regarding the nature of the transaction, such as the action type, number of shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Eric Floyd to the issuer was also not specified. Investors are advised to seek additional information to fully understand the implications of this transaction on their investment decisions.
在最近的一笔交易中,与Virpax Pharmicals Inc. [VRPX] 相关的埃里克·弗洛伊德于2024年1月29日执行了一笔股票交易。公告中没有披露有关交易性质的具体细节,例如行动类型、股票数量、交易价格和股票总价值。埃里克·弗洛伊德与发行人的关系也没有具体说明。建议投资者寻求更多信息,以充分了解该交易对其投资决策的影响。
在最近的一笔交易中,与Virpax Pharmicals Inc. [VRPX] 相关的埃里克·弗洛伊德于2024年1月29日执行了一笔股票交易。公告中没有披露有关交易性质的具体细节,例如行动类型、股票数量、交易价格和股票总价值。埃里克·弗洛伊德与发行人的关系也没有具体说明。建议投资者寻求更多信息,以充分了解该交易对其投资决策的影响。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息